FREE

Section: Wounds

Energy First: Extracorporeal Shockwave Therapy (ESWT) in the Treatment of Diabetic Foot Ulcers

Anthony Tickner, DPM

Anthony Tickner, DPM discusses extracorporeal shockwave therapy (ESWT) and differentiate between types of shockwaves. Dr Tickner, also reviews how pulsed acoustic cellular expression technology interacts with tissues on a cellular level, the mechanism of action on wound healing, as well as clinical studies and real-life cases to demonstrate efficacy.

Goals and Objectives
  1. Discuss Extracorporeal Shockwave Therapy (ESWT) and differentiate between types of shockwaves (ie, electrohydraulic, electromagnetic, and piezoelectric)
  2. Review how a type of ESWT, pulsed acoustic cellular expression technology interacts with the tissue and at the cellular level to trigger a healing response.
  3. Review the mechanism of action focused pulsed acoustic cellular expression technology elicits in wound healing.
  4. Review clinical studies and real-life cases to demonstrate efficacy of focused pulsed acoustic cellular expression technology in relation to standard of care (SOC) in the treatment of diabetic foot ulcers.
  • Author

  • Anthony Tickner, DPM

    Medical Director
    Saint Vincent Hospital/RestorixHealth Wound Care Center
    Worcester, MA

  • System Requirements

  • To view Lectures online, the following specs are required:

    • PC Pentium-III class or better processor
    • 256MB minimum of RAM
    • Cable or DSL broadband Internet
    • Browsers must have javascript enabled. Most browsers have this feature enabled by default.
    • Adobe Acrobat Reader (Free) to print certificates
      • Supported Browsers:
      • Chrome
      • Firefox
      • IE 10+
      • Safari
      Supported Mobile OS:
      • Apple iOS 4.3+
      • Android 2.3+
      • Honeycomb 3.1+
      • Blackberry Playbook
  • Disclosure Information

  • It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.

    ---

    Anthony Tickner has nothing to disclose.

    This continuing education activity is managed and accredited by AffinityCE in cooperation with Present e-Learning Systems. AffinityCE and Present e-Learning Systems Staff, as well as Planners and Reviewers, have no relevant financial interests to disclose. Conflict of Interest when present was resolved through peer review of content by a non-conflicting reviewer.

    Commercial support was not received for this activity.